Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients.
Grodzicki
J
J
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Pardo
M
M
Schved
G
G
Schlosberg
A
A
Fuchs
S
S
Kanety
H
H
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D011569:Psychiatric Status Rating Scales; D011954:Receptors, Dopamine / Q000187:drug effects*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013134:Spiperone / Q000493:pharmacokinetics*
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; C031611:spiroperidol receptor; D013134:Spiperone